{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:19:16Z","timestamp":1794806356991,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clineuro.2026.109443","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:17:20Z","timestamp":1776467840000},"page":"109443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Association between pre-operative long-term aspirin use and post-operative outcomes following extracranial\u2013intracranial bypass for moyamoya disease: National Inpatient Sample analysis"],"prefix":"10.1016","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4373-1888","authenticated-orcid":false,"given":"Rafael T.","family":"Tatit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Rios-Zermeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9600-609X","authenticated-orcid":false,"given":"Abdul Karim","family":"Ghaith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4804-8201","authenticated-orcid":false,"given":"Harsh G.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabih G.","family":"Tawk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clineuro.2026.109443_bib1","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","article-title":"Moyamoya disease: current concepts and future perspectives","volume":"7","author":"Kuroda","year":"2008","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.clineuro.2026.109443_bib2","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jocn.2007.05.033","article-title":"Synchronous moyamoya syndrome and ruptured cerebral aneurysm in Alagille syndrome","volume":"15","author":"Gaba","year":"2008","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109443_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/159101991001600302","article-title":"Endovascular treatment of intracranial aneurysms associated with moyamoya disease or moyamoya syndrome","volume":"16","author":"Yu","year":"2010","journal-title":"Inter. Neuroradiol."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109443_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5853\/jos.2015.01627","article-title":"Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis","volume":"18","author":"Kim","year":"2016","journal-title":"J. Stroke"},{"issue":"16","key":"10.1016\/j.clineuro.2026.109443_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10163628","article-title":"Clinical Management of Moyamoya Patients","volume":"10","author":"Canavero","year":"2021","journal-title":"J. Clin. Med"},{"issue":"5","key":"10.1016\/j.clineuro.2026.109443_bib6","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/STROKEAHA.113.004386","article-title":"Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial","volume":"45","author":"Miyamoto","year":"2014","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.clineuro.2026.109443_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009942","article-title":"Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study)","volume":"6","author":"Onozuka","year":"2016","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.clineuro.2026.109443_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017701","article-title":"Association of antiplatelet therapy, including cilostazol, with improved survival in patients with moyamoya disease in a nationwide study","volume":"10","author":"Seo","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.clineuro.2026.109443_bib9","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00701-020-04668-0","article-title":"Effects of aspirin and heparin treatment on perioperative outcomes in patients with Moyamoya disease","volume":"163","author":"Kanamori","year":"2021","journal-title":"Acta Neurochir. (Wien. )"},{"issue":"4","key":"10.1016\/j.clineuro.2026.109443_bib10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/svn-2020-000770","article-title":"Effects and safety of aspirin use in patients after cerebrovascular bypass procedures","volume":"6","author":"Lu","year":"2021","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.clineuro.2026.109443_bib11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.wneu.2017.06.057","article-title":"Effect of Aspirin in Postoperative Management of Adult Ischemic Moyamoya Disease","volume":"105","author":"Zhao","year":"2017","journal-title":"World Neurosurg."},{"key":"10.1016\/j.clineuro.2026.109443_bib12","article-title":"Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease","volume":"11","author":"Ye","year":"2020","journal-title":"Front Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109443_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.003","article-title":"Effects of Surgery and Antiplatelet Therapy in Ten-Year Follow-Up from the Registry Study of Research Committee on Moyamoya Disease in Japan","volume":"25","author":"Yamada","year":"2016","journal-title":"J. Stroke Cereb. Dis."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109443_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99009-1","article-title":"Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease","volume":"11","author":"Pang","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.clineuro.2026.109443_bib15","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.clineuro.2026.109443_bib16","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1161\/STR.0000000000000443","article-title":"Adult moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the american heart association\/american stroke association","volume":"54","author":"Gonzalez","year":"2023","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.clineuro.2026.109443_bib17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/STROKEAHA.117.018563","article-title":"Surgical management of moyamoya disease","volume":"49","author":"Acker","year":"2018","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.clineuro.2026.109443_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","article-title":"2021 Japanese guidelines for the management of moyamoya disease: guidelines from the research committee on moyamoya disease and japan stroke society","volume":"62","author":"Fujimura","year":"2022","journal-title":"Neurol. Med Chir. (Tokyo"},{"key":"10.1016\/j.clineuro.2026.109443_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.841174","article-title":"Effects of aspirin therapy on bypass efficacy and survival of patients receiving direct cerebral revascularization","volume":"13","author":"Xiang","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.clineuro.2026.109443_bib20","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1046\/j.1440-1789.2000.00300.x","article-title":"Moyamoya disease","volume":"20","author":"Fukui","year":"2000","journal-title":"Neuropathology"},{"issue":"12","key":"10.1016\/j.clineuro.2026.109443_bib21","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott","year":"2009","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.clineuro.2026.109443_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5853\/jos.2015.01760","article-title":"The Pathophysiology of moyamoya disease: an update","volume":"18","author":"Bang","year":"2016","journal-title":"J. Stroke"},{"key":"10.1016\/j.clineuro.2026.109443_bib23","article-title":"Pathophysiology of vascular stenosis and remodeling in moyamoya disease","volume":"12","author":"Fox","year":"2021","journal-title":"Front Neurol."},{"issue":"5 2","key":"10.1016\/j.clineuro.2026.109443_bib24","first-page":"S5","article-title":"Vascular biology of thrombosis: platelet-vessel wall interactions and aspirin effects","volume":"57","author":"Catella-Lawson","year":"2001","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.clineuro.2026.109443_bib25","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/jth.12728","article-title":"Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid","volume":"12","author":"Undas","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109443_bib26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jacc.2015.05.012","article-title":"The multifaceted clinical readouts of platelet inhibition by low-dose aspirin","volume":"66","author":"Patrono","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.clineuro.2026.109443_bib27","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1161\/STROKEAHA.120.030653","article-title":"Association between the onset pattern of adult moyamoya disease and risk factors for stroke","volume":"51","author":"Hirano","year":"2020","journal-title":"Stroke"},{"issue":"1-2","key":"10.1016\/j.clineuro.2026.109443_bib28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jns.2015.11.018","article-title":"Long term outcome and predictors of ischemic stroke recurrence in adult moyamoya disease","volume":"359","author":"Noh","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109443_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3171\/2015.12.JNS151107","article-title":"The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a nationwide Inpatient Sample analysis","volume":"126","author":"Dasenbrock","year":"2017","journal-title":"J. Neurosurg."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109443_bib30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/CCM.0000000000000789","article-title":"Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis","volume":"43","author":"Chen","year":"2015","journal-title":"Crit. Care Med"},{"key":"10.1016\/j.clineuro.2026.109443_bib31","article-title":"Association between aspirin use and decreased risk of pneumonia in patients with cardio-cerebra-vascular ischemic disease: a population-based cohort study","volume":"9","author":"Chen","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.clineuro.2026.109443_bib32","article-title":"The impact of aspirin exposure prior to intensive care unit admission on the outcomes for patients with sepsis-associated acute respiratory failure","volume":"14","author":"Lu","year":"2023","journal-title":"Front Pharm."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726001356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726001356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:30:45Z","timestamp":1782513045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846726001356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"alternative-id":["S0303846726001356"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109443","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between pre-operative long-term aspirin use and post-operative outcomes following extracranial\u2013intracranial bypass for moyamoya disease: National Inpatient Sample analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109443"}}